The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys

Laura Andrade, Jorge J Caraveo‐Anduaga, Patricia Berglund, Rob V Bijl, Ron De Graaf, Wilma Vollebergh, Eva Dragomirecka, Robert Kohn, Martin Keller, Ronald C Kessler, Norito Kawakami, Cengiz Kiliç, David Offord, T Bedirhan Ustun, Hans‐Ulrich Wittchen
2003-02-01
Abstract:Absence of a common diagnostic interview has hampered cross‐national syntheses of epidemiological evidence on major depressive episodes (MDE). Community epidemiological surveys using the World Health Organization Composite International Diagnostic Interview administered face‐to‐face were carried out in 10 countries in North America (Canada and the US), Latin America (Brazil, Chile, and Mexico), Europe (Czech Republic, Germany, the Netherlands, and Turkey), and Asia (Japan). The total sample size was more than 37,000. Lifetime prevalence estimates of hierarchy‐free DSM‐III‐R/DSM‐IV MDE varied widely, from 3% in Japan to 16.9% in the US, with the majority in the range of 8% to 12%. The 12‐month/lifetime prevalence ratio was in the range 40% to 55%, the 30‐day/12‐month prevalence ratio in the range 45% to 65%, and median age of onset in the range 20 to 25 in most countries …
What problem does this paper attempt to address?